Efficacy and safety of TACE combined with TKIs and PD-1 inhibitors in HCC patients with prior TIPS
TACE combined with TKIs and PD-1 inhibitors showed lower efficacy in HCC patients with prior TIPS, but it remains a viable option, providing a favorable safety profile and effective disease control.
Authors
- Huajin Pang (ORCID: https://orcid.org/0000-0001-7367-5701)
- Zhangyun Li
- Kuiyuan Huang
- Kai Xiong (ORCID: https://orcid.org/0000-0002-5863-2700)
- Huizhen Fan (ORCID: https://orcid.org/0000-0001-7646-888X)
- Mingrong Cao (ORCID: https://orcid.org/0000-0001-5672-2991)
- Moran Zhang (ORCID: https://orcid.org/0000-0001-9068-9902)
- Jian Sun (ORCID: https://orcid.org/0000-0002-4732-3152)
- Yuchuan Jiang (ORCID: https://orcid.org/0000-0002-8615-3600)
- Deju Li
- Qiang Li (ORCID: https://orcid.org/0000-0002-4384-8226)
- Yulong Liu (ORCID: https://orcid.org/0000-0003-3630-6936)
- Dandan Zheng (ORCID: https://orcid.org/0000-0002-2571-5526)
- Junjie Liang (ORCID: https://orcid.org/0000-0002-0249-2411)
- Xiaohong Huang (ORCID: https://orcid.org/0000-0001-8274-5070)
- Zhili Wen (ORCID: https://orcid.org/0000-0001-5797-9588)
- Teng-Zheng Li
- Yalu Zheng
Institutions
- Nanchang University (CN)
- Yichun University (CN)
- Nanfang Hospital (CN)
- Second Affiliated Hospital of Nanchang University (CN)
- First Affiliated Hospital of Jinan University (CN)
- First Affiliated Hospital Zhejiang University (CN)
- Southern Medical University (CN)
- Hainan Medical University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-04-24
- DOI
- https://doi.org/10.3389/fonc.2025.1570029
- Citations
- 2
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 3.04
Funders
- National Natural Science Foundation of China
- Basic and Applied Basic Research Foundation of Guangdong Province